retatrutide clinical trial sign up Let's talk about a new weight loss medication: retrarutide. is a triple hormone receptor agonist that suppresses appetite; it also boosts metabolism and increases fat burning, making it one of the Retatrutide Dosing Schedule: Proven 2026

Some drugs belonging to this group are approved for use for weight management among obese and overweight people with comorbidities

A 2023 study of more than 17,000 patients published in the New England Journal of Medicine found that semaglutide reduced the risk of major cardiovascular events including heart attack, stroke and cardiovascular death by about 20% in overweight or obese adults who already have cardiovascular disease but not diabetes

That is what sustainable GLP-1 weight loss actually looks like

How Foods Can Influence GLP-1 Release Naturally Research shows that the types of foods you choose may help stimulate GLP-1 secretion in the gut

Retatrutide recipients exhibited improved glycemic control and reduced insulin resistance

Healthy fats may support GLP-1 response, though evidence is mixed and context-dependent